Darifenacin Hydrobromide extended Release IP 7.5
Nov 02, 2022
Derifenac 7.5
Darifenacin Hydrobromide extended Release IP 7.5 is used to treat an overactive bladder. By relaxing the muscles in the bladder, Darifenacin Hydrobromide extended Release IP 7.5 improves your ability to control your urination. Darifenacin Hydrobromide extended Release IP 7.5 helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
For more information please contact:
Recent Post
Steris Healthcare ELIGOLUX – Effective Solution for Endometriosis Pain Management
What is the Olmesartan, Cilnidipine, and Chlorthalidone Combination Pill For?
How Multivitamin, Multimineral and Amino Acid Tablets with Taurine & Ginseng Support Active Lifestyles
Cinacalcet Tablets 60 mg: When They’re Used and What to Expect
What to Expect When Taking Opipramol 100 mg: A First-Timer’s Guide
How Do Empagliflozin, Linagliptin, and Metformin ER Work Together for Diabetes Control?
Why Doctors Prescribe Pregabalin with Epalrestat and Methylcobalamin for Nerve Pain Steris Healthcare.
Steris Healthcare Pvt Ltd Radiates Excellence at the Dec 2025 ZEE Media Global Innovation & Leadership Summit, London!
Terbinafine 250mg & Itraconazole 100mg: The Ultimate Solution for Stubborn Fungal Infections Steris Healthcare.
Understanding Nebivolol 5mg & S-Amlodipine 2.5mg: A Powerful Combo for Heart Health